Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.2 trillion and total revenue of $111.9 billion.
Market Cap
1.2T
Revenue
111.9B
Profits
-39.99B
PE Ratio
n/a
Profit Margin
-35.74%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.47B | -1.34% | 1,509,944 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.81B | -0.44% | 842,695 | 15.53B |
| 3 | ARGX | argenx SE | 51.97B | -2.70% | 257,838 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 38.79B | -2.71% | 1,827,053 | - |
| 5 | ONC | BeOne Medicines AG | 34.88B | -0.71% | 359,493 | 5.74B |
| 6 | RPRX | Royalty Pharma plc | 32.92B | -2.16% | 2,747,665 | 2.44B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.48B | 7.21% | 3,400,185 | 4.80B |
| 8 | INCY | Incyte Corporation | 24.01B | -0.91% | 1,419,133 | 5.82B |
| 9 | ROIV | Roivant Sciences Ltd. | 23.97B | -1.74% | 5,986,742 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.33B | 1.84% | 1,119,495 | 3.23B |
| 11 | MRNA | Moderna, Inc. | 22.01B | 0.58% | 5,176,713 | 2.23B |
| 12 | INSM | Insmed Incorporated | 21.34B | -0.15% | 3,546,810 | 819.56M |
| 13 | GMAB | Genmab A/S | 17.44B | -0.66% | 1,739,495 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.05B | -0.19% | 622,949 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.80B | -0.51% | 1,493,049 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.63B | -0.16% | 1,366,940 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.84B | 3.83% | 4,270,012 | 2.38B |
| 18 | CORT | Corcept Therapeutics Incorporated | 12.19B | -1.48% | 1,688,525 | 830.81M |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.12B | 1.61% | 1,268,585 | 622.01M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | -0.04% | 1,847,046 | 3.24B |
| 21 | TECH | Bio-Techne Corporation | 11.24B | 0.07% | 3,285,478 | 1.21B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.14B | 3.14% | 463,895 | 1.28B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 10.86B | -3.19% | 962,868 | 708.24M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.64B | -0.11% | 941,540 | 5.67M |
| 25 | SMMT | Summit Therapeutics Inc. | 10.41B | 0.19% | 3,451,628 | - |
| 26 | CYTK | Cytokinetics, Incorporated | 10.38B | -0.88% | 2,239,419 | 105.82M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.07B | 0.01% | 1,059,845 | - |
| 28 | HALO | Halozyme Therapeutics, Inc. | 9.76B | -0.33% | 1,367,643 | 1.51B |
| 29 | KRYS | Krystal Biotech, Inc. | 9.25B | -8.37% | 1,172,009 | 440.48M |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 9.06B | 5.25% | 3,204,897 | 874.09M |
| 31 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.29% | 1,744,758 | 42.16M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 8.52B | -0.75% | 314,971 | 7.46M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 8.51B | -3.19% | 451,134 | 74.06M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.35B | -3.46% | 898,390 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 8.25B | -2.99% | 666,789 | 51.48M |
| 36 | IMVT | Immunovant, Inc. | 7.95B | -0.28% | 704,170 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.73B | -1.02% | 774,681 | - |
| 38 | IBRX | ImmunityBio, Inc. | 7.49B | -0.28% | 8,755,817 | 140.98M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.04B | 3.56% | 964,267 | 217.17M |
| 40 | COGT | Cogent Biosciences, Inc. | 6.64B | -0.18% | 1,405,964 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 6.54B | -11.26% | 6,421,847 | 799.54M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.38B | -1.28% | 500,269 | 569.61M |
| 43 | ERAS | Erasca, Inc. | 6.19B | -1.71% | 2,749,378 | - |
| 44 | CGON | CG Oncology, Inc. | 6.10B | -2.87% | 625,827 | 5.07M |
| 45 | BLTE | Belite Bio, Inc | 6.09B | -2.41% | 191,493 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 6.02B | -0.65% | 540,681 | 7.50M |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 5.80B | -0.84% | 841,705 | 1.34M |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.79B | 1.56% | 191,741 | 274.48M |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.72B | -1.78% | 807,176 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.68B | 0.15% | 1,367,596 | 1.01B |
| 51 | DFTX | Definium Therapeutics, Inc. | 5.55B | -3.98% | 1,902,404 | - |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.49B | -3.07% | 905,223 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.11B | -1.63% | 1,906,548 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.88B | 3.29% | 1,398,571 | 13.39M |
| 55 | DYN | Dyne Therapeutics, Inc. | 4.71B | 0.24% | 2,130,327 | - |
| 56 | CAI | Caris Life Sciences, Inc. | 4.61B | 4.15% | 4,902,409 | 907.29M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.39B | -1.01% | 1,368,055 | 1.10B |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.32B | -0.06% | 696,141 | - |
| 59 | CELC | Celcuity Inc. | 4.28B | 1.55% | 557,283 | - |
| 60 | MANE | Veradermics, Incorporated | 4.26B | -2.96% | 2,765,539 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.13B | -0.13% | 770,687 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.09B | -0.27% | 1,603,488 | 10.68M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.05B | 5.89% | 2,828,372 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.94B | 0.11% | 1,980,994 | 56.99M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.80B | 2.74% | 1,598,814 | - |
| 66 | LEGN | Legend Biotech Corporation | 3.68B | 2.48% | 2,045,213 | 1.14B |
| 67 | DNLI | Denali Therapeutics Inc. | 3.67B | 0.56% | 1,476,102 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.47B | -2.02% | 855,937 | 236.00M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.44B | 0.67% | 326,381 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.40B | 1.31% | 121,754 | 803.79M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.37B | -0.28% | 395,795 | 225.27M |
| 72 | ALMS | Alumis Inc. | 3.33B | -7.54% | 1,387,966 | 8.40M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.24B | -3.43% | 1,570,498 | 415.62M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.21B | -1.08% | 1,012,485 | 22.57M |
| 75 | MBX | MBX Biosciences, Inc. | 3.07B | -2.31% | 390,731 | - |
| 76 | QURE | uniQure N.V. | 3.06B | 0.99% | 1,055,845 | 18.67M |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.96B | -0.97% | 1,635,237 | 865.00K |
| 78 | IRON | Disc Medicine, Inc. | 2.93B | -0.90% | 293,905 | - |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | - | 14,782,848 | 3.49M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | 3.86% | 831,325 | 535.08M |
| 81 | IMNM | Immunome, Inc. | 2.61B | 1.10% | 1,771,163 | 4.02M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.58B | 1.53% | 1,295,033 | 164.01M |
| 83 | TRVI | Trevi Therapeutics, Inc. | 2.54B | -1.92% | 1,255,641 | - |
| 84 | KOD | Kodiak Sciences Inc. | 2.49B | -4.21% | 578,665 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.46B | 0.44% | 2,085,742 | 670.00M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.41B | 0.04% | 1,351,761 | 36.77M |
| 87 | NKTR | Nektar Therapeutics | 2.38B | -0.11% | 611,761 | 55.63M |
| 88 | VCEL | Vericel Corporation | 2.36B | 0.20% | 497,961 | 306.30M |
| 89 | PGEN | Precigen, Inc. | 2.36B | 5.42% | 7,441,191 | 31.60M |
| 90 | VERA | Vera Therapeutics, Inc. | 2.31B | 0.40% | 1,511,397 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | 1.02% | 1,031,857 | - |
| 92 | PHVS | Pharvaris N.V. | 2.25B | -1.13% | 254,477 | - |
| 93 | KLRA | Kailera Therapeutics, Inc. | 2.24B | 2.24% | 357,491 | - |
| 94 | SION | Sionna Therapeutics, Inc. | 2.22B | 4.52% | 508,980 | - |
| 95 | SLS | SELLAS Life Sciences Group, Inc. | 2.21B | 12.09% | 6,968,613 | - |
| 96 | NUVB | Nuvation Bio Inc. | 2.14B | -2.69% | 5,569,327 | 143.05M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 2.13B | 2.06% | 1,833,119 | 70.92M |
| 98 | COAG | Hemab Therapeutics Holdings, Inc. | 2.10B | -5.36% | 699,517 | - |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | 1.02% | 882,815 | 899.11M |
| 100 | ZLAB | Zai Lab Limited | 2.04B | -0.49% | 324,305 | 453.28M |
| 101 | ADMA | ADMA Biologics, Inc. | 2.03B | 3.31% | 2,572,849 | 509.86M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.02B | 1.25% | 145,918 | - |
| 103 | BHVN | Biohaven Ltd. | 2.01B | -0.96% | 1,590,028 | - |
| 104 | NBTX | Nanobiotix S.A. | 1.97B | 1.30% | 151,976 | 38.27M |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.97B | -0.99% | 429,200 | 10.00M |
| 106 | RAPP | Rapport Therapeutics, Inc. | 1.95B | -0.46% | 315,226 | 20.00M |
| 107 | GHRS | GH Research PLC | 1.93B | 0.43% | 241,230 | - |
| 108 | IOVA | Iovance Biotherapeutics, Inc. | 1.93B | 6.02% | 13,022,194 | 285.61M |
| 109 | TYRA | Tyra Biosciences, Inc. | 1.91B | 0.50% | 507,213 | - |
| 110 | URGN | UroGen Pharma Ltd. | 1.88B | 0.92% | 964,663 | 140.49M |
| 111 | AUPH | Aurinia Pharmaceuticals Inc. | 1.87B | -2.08% | 1,404,085 | 298.30M |
| 112 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.01% | 649,694 | - |
| 113 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | -1.37% | 1,963,182 | 7.47M |
| 114 | MESO | Mesoblast Limited | 1.85B | 2.12% | 228,636 | 65.38M |
| 115 | OCUL | Ocular Therapeutix, Inc. | 1.84B | 2.82% | 3,327,328 | 52.06M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.84B | 2.43% | 3,151,995 | 27.59M |
| 117 | GENB | Generate Biomedicines, Inc. | 1.84B | 2.43% | 275,072 | 30.30M |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.82B | 1.73% | 1,189,501 | 98.34M |
| 119 | FTRE | Fortrea Holdings Inc. | 1.80B | -1.20% | 3,139,899 | 2.68B |
| 120 | KARD | Kardigan, Inc. | 1.78B | -4.08% | 224,747 | - |
| 121 | ABCL | AbCellera Biologics Inc. | 1.78B | 2.10% | 3,405,575 | 79.21M |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.78B | -1.76% | 200,170 | 1.20B |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.76B | -1.48% | 227,689 | - |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | 1.00% | 1,610,966 | 217.17M |
| 125 | BCAX | Bicara Therapeutics Inc. | 1.69B | -5.02% | 398,951 | - |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | 6.00% | 14,721,699 | 66.41M |
| 127 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 6.86% | 3,799,658 | 2.18B |
| 128 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.66B | -2.28% | 2,047,046 | 204.73M |
| 129 | IMCR | Immunocore Holdings plc | 1.65B | -4.08% | 645,650 | 412.81M |
| 130 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | 4.81% | 259,633 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.59B | 0.56% | 433,726 | 232.39M |
| 132 | SEPN | Septerna, Inc. | 1.58B | 1.54% | 201,792 | 72.26M |
| 133 | ZYME | Zymeworks Inc. | 1.56B | -0.59% | 398,262 | 81.26M |
| 134 | INVA | Innoviva, Inc. | 1.53B | -0.95% | 799,096 | 420.69M |
| 135 | AAPG | Ascentage Pharma Group International | 1.53B | -3.59% | 14,157 | 82.08M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.51B | 1.52% | 313,331 | 20.00M |
| 137 | NTLA | Intellia Therapeutics, Inc. | 1.50B | 0.84% | 3,319,884 | 66.09M |
| 138 | VIR | Vir Biotechnology, Inc. | 1.50B | 2.77% | 1,241,558 | 65.50M |
| 139 | XNCR | Xencor, Inc. | 1.44B | -4.01% | 714,400 | 97.36M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.44B | -5.64% | 1,272,660 | - |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -0.60% | 278,248 | - |
| 142 | SVRA | Savara Inc. | 1.35B | -2.38% | 1,639,559 | - |
| 143 | ABSI | Absci Corporation | 1.34B | 1.93% | 2,220,106 | 1.84M |
| 144 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30B | -6.90% | 2,317,063 | 42.95M |
| 145 | AVLN | Avalyn Pharma Inc. | 1.26B | -1.01% | 110,852 | - |
| 146 | IMTX | Immatics N.V. | 1.23B | 4.16% | 257,445 | 43.00M |
| 147 | ARDX | Ardelyx, Inc. | 1.23B | 0.61% | 2,919,404 | 427.68M |
| 148 | AKTS | Aktis Oncology, Inc. | 1.23B | 0.72% | 314,667 | 8.28M |
| 149 | LBRX | LB Pharmaceuticals Inc | 1.23B | 6.89% | 871,758 | - |
| 150 | NVAX | Novavax, Inc. | 1.22B | 1.23% | 2,580,452 | 596.34M |
| 151 | MNKD | MannKind Corporation | 1.21B | -2.81% | 5,271,228 | 360.78M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.21B | 0.82% | 134,457 | 1.30M |
| 153 | VOR | Vor Biopharma Inc. | 1.16B | 1.23% | 851,887 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 1.14B | -3.04% | 651,159 | - |
| 155 | WVE | Wave Life Sciences Ltd. | 1.13B | 4.17% | 3,417,765 | 65.37M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | 0.83% | 580,650 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.11B | 0.93% | 139,525 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.10B | 0.76% | 489,489 | 79.76M |
| 159 | ORIC | ORIC Pharmaceuticals, Inc. | 1.10B | -4.25% | 2,460,195 | - |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.08B | 1.10% | 330,397 | - |
| 161 | ANRO | Alto Neuroscience, Inc. | 1.06B | 0.74% | 409,063 | - |
| 162 | EYPT | EyePoint, Inc. | 1.04B | 1.39% | 1,479,286 | 7.61M |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | 0.87% | 2,053,054 | 69.64M |
| 164 | IVA | Inventiva S.A. | 1.03B | -5.13% | 1,005,400 | 7.94M |
| 165 | REPL | Replimune Group, Inc. | 1.00B | 6.34% | 11,770,443 | - |
| 166 | CGEM | Cullinan Therapeutics, Inc. | 998.69M | -1.52% | 386,581 | - |
| 167 | APMD | Apnimed, Inc. | 995.58M | - | 700,677 | 120.15M |
| 168 | OLMA | Olema Pharmaceuticals, Inc. | 985.28M | -1.48% | 763,683 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 954.90M | -1.10% | 572,280 | 59.00K |
| 170 | SANA | Sana Biotechnology, Inc. | 953.68M | 1.60% | 2,490,023 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 934.28M | 0.99% | 558,891 | 13.73M |
| 172 | OMER | Omeros Corporation | 909.03M | 6.08% | 1,446,043 | 9.89M |
| 173 | TBPH | Theravance Biopharma, Inc. | 874.34M | - | 436,747 | 109.78M |
| 174 | ODTX | Odyssey Therapeutics, Inc. | 868.03M | -4.23% | 141,343 | 1.06M |
| 175 | ABUS | Arbutus Biopharma Corporation | 861.26M | 0.46% | 1,421,188 | 191.45M |
| 176 | ANNX | Annexon, Inc. | 860.17M | 2.94% | 2,691,768 | - |
| 177 | GERN | Geron Corporation | 821.15M | -0.78% | 19,560,303 | 196.12M |
| 178 | TENX | Tenax Therapeutics, Inc. | 820.85M | 4.60% | 2,000,706 | - |
| 179 | KURA | Kura Oncology, Inc. | 815.84M | 2.00% | 1,154,592 | 71.64M |
| 180 | DSGN | Design Therapeutics, Inc. | 798.54M | 4.76% | 477,903 | - |
| 181 | DBVT | DBV Technologies S.A. | 789.92M | 0.59% | 304,565 | 5.04M |
| 182 | SLDB | Solid Biosciences Inc. | 789.57M | -0.50% | 905,524 | - |
| 183 | AURA | Aura Biosciences, Inc. | 776.51M | 0.43% | 422,224 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 772.34M | 6.35% | 1,951,997 | 8.37M |
| 185 | SGP | SpyGlass Pharma, Inc. | 758.27M | 0.67% | 103,533 | - |
| 186 | MNPR | Monopar Therapeutics Inc. | 747.85M | 3.04% | 489,202 | - |
| 187 | CADL | Candel Therapeutics, Inc. | 737.83M | 0.60% | 879,390 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 721.25M | 0.71% | 275,400 | - |
| 189 | PHAR | Pharming Group N.V. | 718.94M | -2.58% | 33,855 | 366.48M |
| 190 | OCS | Oculis Holding AG | 718.01M | 5.13% | 295,716 | 1.40M |
| 191 | PHAT | Phathom Pharmaceuticals, Inc. | 713.28M | 2.63% | 1,533,999 | 239.66M |
| 192 | FTH | Faeth Therapeutics, Inc. | 704.79M | 0.37% | 287,922 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 692.53M | 1.68% | 187,266 | 299.77M |
| 194 | CTMX | CytomX Therapeutics, Inc. | 690.12M | 2.26% | 3,795,998 | 35.54M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 681.20M | 6.26% | 53,648 | 117.05M |
| 196 | NVCT | Nuvectis Pharma, Inc. | 680.95M | 0.37% | 204,311 | - |
| 197 | CLYM | Climb Bio, Inc. | 676.25M | -0.76% | 847,422 | - |
| 198 | AGMB | AgomAb Therapeutics NV | 665.83M | 5.05% | 126,059 | - |
| 199 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 660.88M | 1.98% | 210,048 | - |
| 200 | NGNE | Neurogene Inc. | 655.00M | -0.06% | 155,547 | 925.00K |
| 201 | ACHV | Achieve Life Sciences, Inc. | 648.81M | -1.56% | 914,000 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 636.45M | 2.76% | 236,356 | 11.88M |
| 203 | ALLO | Allogene Therapeutics, Inc. | 635.08M | -2.13% | 7,012,056 | 22.00K |
| 204 | MDXG | MiMedx Group, Inc. | 622.40M | 3.39% | 1,869,210 | 355.17M |
| 205 | RGNX | REGENXBIO Inc. | 614.56M | 2.79% | 812,863 | 87.82M |
| 206 | IMMX | Immix Biopharma, Inc. | 599.42M | 1.20% | 1,618,136 | - |
| 207 | CTNM | Contineum Therapeutics, Inc. | 599.30M | 2.84% | 315,033 | - |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 594.40M | 5.73% | 1,753,732 | 122.29M |
| 209 | CRMD | CorMedix Inc. | 592.31M | 0.27% | 856,025 | 400.05M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 584.00M | 10.51% | 1,421,374 | 151.40M |
| 211 | ALT | Altimmune, Inc. | 583.42M | 5.63% | 4,647,347 | 36.00K |
| 212 | MPLT | MapLight Therapeutics, Inc. | 569.09M | -3.61% | 999,857 | - |
| 213 | STTK | Shattuck Labs, Inc. | 559.00M | 3.11% | 989,701 | 1.00M |
| 214 | RLMD | Relmada Therapeutics, Inc. | 555.92M | -0.19% | 1,073,321 | - |
| 215 | SPRY | ARS Pharmaceuticals, Inc. | 542.20M | 6.43% | 2,143,695 | 98.99M |
| 216 | SLBT | SL Science Holding Limited | 531.75M | 24.39% | 198,490 | 3.27M |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 527.47M | -0.88% | 463,644 | 88.24M |
| 218 | TECX | Tectonic Therapeutic, Inc. | 526.83M | -0.39% | 106,035 | - |
| 219 | ZURA | Zura Bio Limited | 524.39M | 1.66% | 435,189 | - |
| 220 | ARTV | Artiva Biotherapeutics, Inc. | 522.81M | 6.53% | 572,312 | 251.00K |
| 221 | ARVN | Arvinas, Inc. | 520.04M | 0.37% | 716,843 | 89.40M |
| 222 | ANL | Adlai Nortye Ltd. | 519.60M | -0.08% | 216,583 | 5.00M |
| 223 | RZLT | Rezolute, Inc. | 512.93M | 4.03% | 1,428,172 | - |
| 224 | PRME | Prime Medicine, Inc. | 507.54M | -3.77% | 3,953,389 | 4.03M |
| 225 | SLN | Silence Therapeutics plc | 504.46M | 1.81% | 536,743 | 839.00K |
| 226 | VSTM | Verastem, Inc. | 500.00M | -1.90% | 1,288,053 | 49.59M |
| 227 | HELP | Cybin Inc. | 499.59M | 3.07% | 1,199,700 | - |
| 228 | EIKN | Eikon Therapeutics, Inc. | 495.37M | -0.65% | 256,653 | - |
| 229 | ASMB | Assembly Biosciences, Inc. | 488.20M | 1.00% | 193,302 | 71.10M |
| 230 | AUTL | Autolus Therapeutics plc | 484.38M | 22.15% | 13,440,416 | 92.62M |
| 231 | VALN | Valneva SE | 476.79M | 2.01% | 7,565 | 180.25M |
| 232 | PROK | ProKidney Corp. | 471.21M | 1.30% | 591,743 | 889.00K |
| 233 | KYTX | Kyverna Therapeutics, Inc. | 456.57M | 2.88% | 822,328 | - |
| 234 | QTTB | Q32 Bio Inc. | 451.37M | -3.28% | 328,943 | 53.74M |
| 235 | SGMT | Sagimet Biosciences Inc. | 441.53M | 0.56% | 2,991,035 | - |
| 236 | CABA | Cabaletta Bio, Inc. | 438.62M | 0.37% | 1,873,047 | - |
| 237 | PRTA | Prothena Corporation plc | 436.10M | 2.59% | 565,762 | 57.94M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 435.39M | -4.57% | 288,733 | 16.72M |
| 239 | OVID | Ovid Therapeutics Inc. | 434.87M | 4.95% | 1,677,479 | 7.12M |
| 240 | IKT | Inhibikase Therapeutics, Inc. | 431.88M | 1.38% | 486,556 | 1.00 |
| 241 | OCGN | Ocugen, Inc. | 423.15M | 1.63% | 3,549,203 | 4.47M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 418.17M | 1.72% | 98,459 | - |
| 243 | EVMN | Evommune, Inc. | 417.45M | 3.02% | 862,586 | 10.00M |
| 244 | BNTC | Benitec Biopharma Inc. | 417.41M | 3.76% | 101,950 | - |
| 245 | STRO | Sutro Biopharma, Inc. | 415.92M | 3.85% | 179,977 | 99.61M |
| 246 | LRMR | Larimar Therapeutics, Inc. | 415.44M | 4.19% | 793,826 | - |
| 247 | EDIT | Editas Medicine, Inc. | 406.67M | 2.71% | 775,116 | 38.69M |
| 248 | VTVT | vTv Therapeutics Inc. | 401.94M | 0.12% | 171,175 | 36.84M |
| 249 | SCTX | Scribe Therapeutics Inc. | 393.04M | 6.96% | 99,114 | 36.28M |
| 250 | PBYI | Puma Biotechnology, Inc. | 391.42M | -3.03% | 338,507 | 227.18M |
| 251 | CCCC | C4 Therapeutics, Inc. | 386.99M | 0.57% | 2,244,168 | 34.86M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 385.77M | 2.76% | 364,063 | 9.01M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 376.57M | 2.78% | 168,144 | 69.21M |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 372.35M | 9.65% | 3,167,826 | - |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 368.92M | -1.91% | 230,119 | - |
| 256 | ABEO | Abeona Therapeutics Inc. | 364.20M | -0.47% | 1,008,655 | 14.54M |
| 257 | IPSC | Century Therapeutics, Inc. | 357.10M | -1.98% | 572,027 | 109.16M |
| 258 | DMAC | DiaMedica Therapeutics Inc. | 351.32M | 2.84% | 171,969 | - |
| 259 | AGEN | Agenus Inc. | 349.96M | 4.27% | 1,654,214 | 123.87M |
| 260 | UPB | Upstream Bio, Inc. | 349.38M | 1.74% | 774,288 | 3.32M |
| 261 | CMPX | Compass Therapeutics, Inc. | 339.47M | -1.31% | 3,510,562 | 850.00K |
| 262 | PALI | Palisade Bio, Inc. | 336.74M | 2.37% | 1,027,155 | - |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 333.13M | 0.21% | 117,839 | 51.00M |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 331.02M | -1.90% | 820,477 | 26.87M |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 329.79M | 1.69% | 667,153 | - |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 323.25M | 6.93% | 2,386 | 64.24M |
| 267 | VCRE | Vicore Pharma Holding AB (publ) | 316.62M | 1.14% | 5,634 | 370.61K |
| 268 | LYEL | Lyell Immunopharma, Inc. | 315.37M | -0.54% | 85,939 | 31.00K |
| 269 | VNDA | Vanda Pharmaceuticals Inc. | 314.51M | 2.55% | 719,828 | 217.78M |
| 270 | NMRA | Neumora Therapeutics, Inc. | 303.87M | 1.86% | 392,469 | - |
| 271 | IRD | Opus Genetics, Inc. | 300.54M | -1.89% | 958,375 | 11.98M |
| 272 | FATE | Fate Therapeutics, Inc. | 291.40M | 2.04% | 1,252,687 | 6.32M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 289.80M | 6.16% | 676,190 | 114.70K |
| 274 | OABI | OmniAb, Inc. | 284.15M | -1.01% | 228,557 | 28.94M |
| 275 | FULC | Fulcrum Therapeutics, Inc. | 283.06M | 3.63% | 2,262,369 | 80.00M |
| 276 | NAGE | Niagen Bioscience, Inc. | 281.73M | 3.82% | 1,263,815 | 130.42M |
| 277 | LCTX | Lineage Cell Therapeutics, Inc. | 276.72M | 2.78% | 680,718 | 14.78M |
| 278 | AVXL | Anavex Life Sciences Corp. | 273.38M | 7.27% | 1,443,797 | - |
| 279 | FHTX | Foghorn Therapeutics Inc. | 270.67M | 1.77% | 214,169 | 28.22M |
| 280 | BCYC | Bicycle Therapeutics plc | 270.17M | 0.26% | 340,368 | 61.21M |
| 281 | IMRX | Immuneering Corporation | 269.79M | 0.97% | 497,531 | - |
| 282 | SLGL | Sol-Gel Technologies Ltd. | 268.02M | -0.32% | 87,189 | 18.47M |
| 283 | ELDN | Eledon Pharmaceuticals, Inc. | 265.15M | 1.48% | 1,601,067 | - |
| 284 | TTRX | Turn Therapeutics Inc. | 263.33M | 5.74% | 12,287 | - |
| 285 | TRDA | Entrada Therapeutics, Inc. | 261.60M | 6.92% | 500,400 | 5.74M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 259.71M | -0.52% | 564,485 | - |
| 287 | IFRX | InflaRx N.V. | 257.76M | 2.94% | 557,821 | 33.82K |
| 288 | SRZN | Surrozen, Inc. | 252.87M | -1.94% | 230,409 | 7.49M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 246.71M | 3.52% | 187,232 | 32.72M |
| 290 | CAPR | Capricor Therapeutics, Inc. | 243.23M | 9.09% | 5,166,955 | 11.13M |
| 291 | MGNX | MacroGenics, Inc. | 242.81M | 3.52% | 497,659 | 157.08M |
| 292 | PRQR | ProQR Therapeutics N.V. | 241.32M | -0.58% | 558,955 | 15.73M |
| 293 | ADAG | Adagene Inc. | 239.84M | -3.20% | 72,812 | 7.67M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 231.23M | 0.90% | 111,930 | 1.78M |
| 295 | CGEN | Compugen Ltd. | 225.11M | 1.28% | 592,846 | 74.00M |
| 296 | TARA | Protara Therapeutics, Inc. | 223.13M | 1.28% | 241,565 | - |
| 297 | CHRS | Coherus Oncology, Inc. | 222.12M | 2.13% | 477,275 | 46.88M |
| 298 | ACIU | AC Immune SA | 220.23M | 1.37% | 118,316 | 4.62M |
| 299 | CAMP | Camp4 Therapeutics Corporation | 218.61M | 22.03% | 295,963 | 3.93M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 212.98M | 2.86% | 328,968 | 7.15M |
| 301 | CNXU | Conexeu Sciences Inc. | 207.64M | -6.62% | 131,853 | - |
| 302 | CLLS | Cellectis S.A. | 202.66M | - | 3,187 | 75.11M |
| 303 | ANTX | AN2 Therapeutics, Inc. | 200.97M | 4.30% | 305,993 | - |
| 304 | KROS | Keros Therapeutics, Inc. | 200.10M | 0.40% | 154,058 | 33.18M |
| 305 | GALT | Galectin Therapeutics Inc. | 199.55M | 2.02% | 296,898 | - |
| 306 | GLSI | Greenwich LifeSciences, Inc. | 198.74M | 0.30% | 123,179 | - |
| 307 | RNA | Atrium Therapeutics, Inc. | 193.81M | -0.18% | 91,504 | 36.68M |
| 308 | PYXS | Pyxis Oncology, Inc. | 192.60M | 14.72% | 1,135,158 | 13.86M |
| 309 | IMUX | Immunic, Inc. | 192.06M | 0.93% | 169,619 | - |
| 310 | PLX | Protalix BioTherapeutics, Inc. | 186.93M | -2.11% | 1,027,427 | 76.38M |
| 311 | NBP | NovaBridge Biosciences | 186.19M | 0.63% | 168,584 | - |
| 312 | HUMA | Humacyte, Inc. | 185.86M | 5.49% | 3,267,165 | 2.02M |
| 313 | ARMP | Armata Pharmaceuticals, Inc. | 185.39M | 11.23% | 60,161 | 5.20M |
| 314 | NERV | Minerva Neurosciences, Inc. | 184.96M | -0.25% | 83,769 | - |
| 315 | ACOG | Alpha Cognition Inc. | 183.56M | 1.81% | 70,698 | 10.83M |
| 316 | MDWD | MediWound Ltd. | 182.76M | 0.71% | 60,571 | 14.48M |
| 317 | DTIL | Precision BioSciences, Inc. | 182.16M | 1.00% | 285,973 | 45.07M |
| 318 | VYGR | Voyager Therapeutics, Inc. | 181.26M | -0.99% | 610,348 | 36.49M |
| 319 | ORMP | Oramed Pharmaceuticals Inc. | 179.67M | 7.86% | 282,517 | 2.00M |
| 320 | NGEN | NervGen Pharma Corp. | 174.52M | 1.23% | 238,037 | - |
| 321 | OTLK | Outlook Therapeutics, Inc. | 170.73M | -6.51% | 5,993,462 | 333.14K |
| 322 | ARCT | Arcturus Therapeutics Holdings Inc. | 170.54M | 4.17% | 254,611 | 54.71M |
| 323 | TNXP | Tonix Pharmaceuticals Holding Corp. | 170.01M | 6.54% | 347,822 | 17.56M |
| 324 | ALEC | Alector, Inc. | 167.65M | - | 359,921 | 18.42M |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 165.27M | -0.56% | 131,925 | - |
| 326 | IPHA | Innate Pharma S.A. | 165.13M | -1.71% | 47,280 | 10.57M |
| 327 | IVVD | Invivyd, Inc. | 162.51M | 3.10% | 2,455,493 | 55.87M |
| 328 | OKUR | OnKure Therapeutics, Inc. | 162.39M | 5.24% | 160,231 | - |
| 329 | YDES | YD Bio Limited | 161.74M | 5.99% | 142,886 | 510.36K |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 158.19M | -1.53% | 2,062,438 | 225.00K |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 157.46M | 1.40% | 227,452 | - |
| 332 | LENZ | LENZ Therapeutics, Inc. | 156.62M | -5.75% | 1,030,619 | 20.99M |
| 333 | MOLN | Molecular Partners AG | 155.33M | 4.83% | 6,089 | 856.30K |
| 334 | KRRO | Korro Bio, Inc. | 154.90M | 3.57% | 94,693 | 3.84M |
| 335 | AARD | Aardvark Therapeutics, Inc. | 154.46M | 7.27% | 96,139 | - |
| 336 | CNTN | Canton Strategic Holdings, Inc. | 154.25M | 3.63% | 1,056,360 | - |
| 337 | NKTX | Nkarta, Inc. | 153.82M | 2.87% | 610,000 | - |
| 338 | MIST | Milestone Pharmaceuticals Inc. | 152.38M | 0.90% | 935,450 | 1.78M |
| 339 | CRBU | Caribou Biosciences, Inc. | 148.77M | 2.74% | 1,391,009 | 11.20M |
| 340 | MENS | Jyong Biotech Ltd. | 148.47M | -6.98% | 73,530 | - |
| 341 | INDP | Indaptus Therapeutics, Inc. | 148.35M | 1.55% | 73,854 | - |
| 342 | ENTX | Entera Bio Ltd. | 145.90M | -1.00% | 1,102,023 | 42.00K |
| 343 | CBUS | Cibus, Inc. | 144.27M | -2.07% | 168,955 | 4.29M |
| 344 | KZIA | Kazia Therapeutics Limited | 141.81M | -1.66% | 197,331 | 1.27M |
| 345 | EQ | Equillium, Inc. | 139.10M | - | 523,642 | 4.39M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 138.47M | 0.90% | 588,025 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 136.28M | -1.38% | 207,929 | - |
| 348 | NRXP | NRx Pharmaceuticals, Inc. | 135.79M | 2.86% | 617,220 | 2.29M |
| 349 | GNLX | Genelux Corporation | 132.34M | 1.36% | 219,561 | 8.00K |
| 350 | CDXS | Codexis, Inc. | 131.80M | 3.57% | 805,955 | 78.09M |
| 351 | PEPG | PepGen Inc. | 130.04M | 6.82% | 347,447 | - |
| 352 | NAUT | Nautilus Biotechnology, Inc. | 128.53M | 3.38% | 1,225,046 | 190.00K |
| 353 | PMN | ProMIS Neurosciences, Inc. | 126.80M | 3.06% | 17,884 | - |
| 354 | TLSA | Tiziana Life Sciences Ltd | 125.34M | -5.89% | 3,012,491 | - |
| 355 | CNTB | Connect Biopharma Holdings Limited | 124.04M | -2.48% | 259,403 | 233.00K |
| 356 | SEER | Seer, Inc. | 123.16M | 0.90% | 534,568 | 15.17M |
| 357 | SPRB | Spruce Biosciences, Inc. | 118.73M | 0.72% | 48,265 | 697.00K |
| 358 | ENGN | enGene Therapeutics Inc. | 118.57M | -1.12% | 525,494 | - |
| 359 | ANIX | Anixa Biosciences, Inc. | 116.02M | -0.29% | 149,737 | - |
| 360 | VANI | Vivani Medical, Inc. | 114.69M | 3.91% | 146,163 | - |
| 361 | CUE | Cue Biopharma, Inc. | 112.86M | 0.11% | 141,251 | 32.73M |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 109.26M | 3.51% | 618,187 | 3.17M |
| 363 | GUTS | Fractyl Health, Inc. | 107.44M | -1.14% | 661,720 | 3.00K |
| 364 | COYA | Coya Therapeutics, Inc. | 103.92M | 5.73% | 116,694 | 7.94M |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 103.68M | -5.19% | 97,179 | - |
| 366 | ICCC | ImmuCell Corporation | 99.88M | -1.52% | 16,438 | 29.93M |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 99.42M | 2.66% | 429,490 | 70.00M |
| 368 | ACET | Adicet Bio, Inc. | 97.03M | 1.43% | 135,437 | - |
| 369 | HRTX | Heron Therapeutics, Inc. | 96.80M | 3.06% | 1,505,996 | 150.71M |
| 370 | KLRS | Kalaris Therapeutics, Inc. | 96.36M | 15.38% | 156,594 | - |
| 371 | YARW | Yarrow Bioscience, Inc. | 94.05M | -4.08% | 16,075 | - |
| 372 | PTHS | Pelthos Therapeutics Inc. | 93.29M | -6.35% | 374,480 | 27.70M |
| 373 | ONCY | Oncolytics Biotech Inc. | 92.50M | 2.88% | 746,879 | - |
| 374 | ALDX | Aldeyra Therapeutics, Inc. | 92.29M | -0.65% | 784,764 | - |
| 375 | FBIO | Fortress Biotech, Inc. | 91.68M | -11.82% | 2,313,305 | 66.16M |
| 376 | VRCA | Verrica Pharmaceuticals Inc. | 90.19M | 0.57% | 32,362 | 37.16M |
| 377 | ATHE | Alterity Therapeutics Limited | 89.80M | 0.95% | 3,668 | 4.43M |
| 378 | NTHI | NeOnc Technologies Holdings, Inc. | 89.73M | -0.86% | 39,813 | 39.99K |
| 379 | OKYO | OKYO Pharma Limited | 87.64M | -0.60% | 18,158 | - |
| 380 | BMEA | Biomea Fusion, Inc. | 86.76M | 2.56% | 844,008 | - |
| 381 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | 2.48% | 54,904 | - |
| 382 | GOSS | Gossamer Bio, Inc. | 84.86M | 2.42% | 17,705,154 | 55.54M |
| 383 | RLYB | Rallybio Corporation | 84.51M | 0.13% | 19,597 | 858.00K |
| 384 | PYPD | PolyPid Ltd. | 83.60M | 1.63% | 269,750 | - |
| 385 | NRXS | NeurAxis, Inc. | 81.61M | 5.44% | 78,708 | 4.28M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 80.26M | 5.60% | 650,171 | - |
| 387 | CSBR | Champions Oncology, Inc. | 80.03M | 7.46% | 2,931 | 59.43M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 79.79M | 0.21% | 324,240 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 77.04M | 2.03% | 53,225 | 23.14M |
| 390 | GANX | Gain Therapeutics, Inc. | 74.64M | 4.17% | 390,862 | - |
| 391 | ELOX | Eloxx Pharmaceuticals, Inc. | 74.47M | 5.85% | 65,760 | - |
| 392 | ANVS | Annovis Bio, Inc. | 73.17M | -1.71% | 460,197 | - |
| 393 | IBIO | iBio, Inc. | 70.54M | 1.43% | 470,250 | 300.00K |
| 394 | LONA | LeonaBio, Inc. | 70.17M | 5.81% | 11,021 | - |
| 395 | OSTX | OS Therapies Incorporated | 69.03M | 1.97% | 214,291 | - |
| 396 | XBIT | XBiotech Inc. | 68.14M | 0.22% | 12,274 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 67.07M | 2.14% | 293,730 | - |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 66.77M | 4.00% | 242,010 | - |
| 399 | SPRO | Spero Therapeutics, Inc. | 66.59M | -1.71% | 1,373,121 | 61.19M |
| 400 | ALPS | Alps Group Inc | 66.04M | -3.27% | 4,787 | 3.74M |
| 401 | MNOV | MediciNova, Inc. | 65.46M | - | 39,189 | 596.64K |
| 402 | CING | Cingulate Inc. | 65.06M | 0.84% | 135,335 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 64.40M | - | 161,726 | - |
| 404 | CRDF | Cardiff Oncology, Inc. | 63.86M | 9.19% | 1,285,370 | 525.00K |
| 405 | RNTX | Rein Therapeutics Inc. | 63.77M | 1.10% | 139,305 | - |
| 406 | IMA | ImageneBio, Inc. | 63.61M | 1.81% | 3,813 | 800.00K |
| 407 | HYFT | MindWalk Holdings Corp. | 63.06M | 4.65% | 136,076 | 11.43M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 59.73M | 0.90% | 2,105,489 | - |
| 409 | BOLD | Boundless Bio, Inc. | 57.73M | 2.80% | 317,994 | - |
| 410 | DWTX | Dogwood Therapeutics, Inc. | 57.51M | 4.27% | 84,345 | - |
| 411 | INO | Inovio Pharmaceuticals, Inc. | 57.33M | 2.92% | 7,630,984 | 65.34K |
| 412 | CNTX | Context Therapeutics Inc. | 55.50M | 0.78% | 1,480,754 | - |
| 413 | XLO | Xilio Therapeutics, Inc. | 54.14M | -0.66% | 18,827 | 53.48M |
| 414 | INKT | MiNK Therapeutics, Inc. | 53.26M | 1.81% | 5,614 | - |
| 415 | MREO | Mereo BioPharma Group plc | 50.36M | -7.94% | 964,402 | 500.00K |
| 416 | FLNA | Filana Therapeutics, Inc. | 49.76M | 1.98% | 324,108 | - |
| 417 | INMB | INmune Bio Inc. | 49.18M | 5.71% | 222,487 | 50.00K |
| 418 | TIL | Instil Bio, Inc. | 48.97M | 1.40% | 10,340 | - |
| 419 | MCRB | Seres Therapeutics, Inc. | 48.71M | 4.14% | 29,841 | 1.15M |
| 420 | ATYR | aTyr Pharma, Inc. | 48.24M | 1.30% | 774,599 | 190.00K |
| 421 | BYSI | BeyondSpring Inc. | 48.11M | 1.74% | 15,253 | 1.88M |
| 422 | RNXT | RenovoRx, Inc. | 47.81M | 10.61% | 703,841 | 1.49M |
| 423 | IMMP | Immutep Limited | 47.44M | -0.42% | 144,665 | 5.28M |
| 424 | IBO | Impact BioMedical Inc. | 47.33M | 2.09% | 20,845 | 39.00K |
| 425 | TCRX | TScan Therapeutics, Inc. | 47.27M | -2.64% | 441,443 | 9.14M |
| 426 | EDSA | Edesa Biotech, Inc. | 46.50M | 2.35% | 39,123 | - |
| 427 | VRXA | Veraxa Biotech AG | 46.15M | 3.98% | 89,311 | - |
| 428 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | 1.68% | 134,023 | 22.33M |
| 429 | KPTI | Karyopharm Therapeutics Inc. | 44.65M | 2.60% | 4,514,606 | 151.12M |
| 430 | HYPD | Hyperion DeFi, Inc. | 40.32M | 0.76% | 369,693 | 1.04M |
| 431 | PDSB | PDS Biotechnology Corporation | 39.87M | 4.12% | 248,183 | - |
| 432 | EXOZ | eXoZymes, Inc. | 39.00M | -1.08% | 12,406 | -700.00 |
| 433 | DYAI | Dyadic International, Inc. | 38.63M | 0.95% | 53,651 | 3.81M |
| 434 | APLM | Apollomics, Inc. | 37.38M | -1.33% | 8,036 | 8.84M |
| 435 | VERU | Veru Inc. | 36.27M | 0.89% | 236,718 | 16.89M |
| 436 | RADX | Radiopharm Theranostics Limited | 35.74M | -1.27% | 83,938 | 10.86M |
| 437 | NNVC | NanoViricides, Inc. | 35.31M | 1.97% | 510,858 | - |
| 438 | CRVO | CervoMed Inc. | 35.17M | 0.78% | 122,536 | 2.09M |
| 439 | ENLV | Enlivex Ltd. | 34.87M | 3.83% | 271,111 | - |
| 440 | NTRB | Nutriband Inc. | 34.16M | -1.40% | 5,601 | 1.80M |
| 441 | GRCE | Grace Therapeutics, Inc. | 33.85M | - | 96,020 | - |
| 442 | LITS | Lite Strategy, Inc. | 33.39M | 1.84% | 93,368 | - |
| 443 | LTRN | Lantern Pharma Inc. | 33.30M | -0.76% | 115,169 | - |
| 444 | GNTA | Genenta Science S.p.A. | 33.26M | -5.37% | 36,314 | - |
| 445 | SER | Serina Therapeutics, Inc. | 30.89M | 3.00% | 17,640 | 130.00K |
| 446 | ESLA | Estrella Immunopharma, Inc. | 30.12M | -1.92% | 26,905 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 29.89M | -2.33% | 144,561 | - |
| 448 | TVGN | Tevogen Bio Holdings Inc. | 29.62M | -0.43% | 20,858 | - |
| 449 | ALGS | Aligos Therapeutics, Inc. | 28.47M | 8.75% | 134,956 | 4.71M |
| 450 | KYNB | Kyntra Bio, Inc. | 27.37M | 0.45% | 4,981 | 7.44M |
| 451 | ABVC | ABVC BioPharma, Inc. | 26.28M | 2.97% | 68,107 | 797.92K |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 25.46M | -3.04% | 200,148 | 90.00K |
| 453 | ACTU | Actuate Therapeutics, Inc. | 25.36M | -4.50% | 174,798 | - |
| 454 | IGC | IGC Pharma, Inc. | 24.53M | -1.57% | 376,407 | 1.11M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 24.51M | 7.55% | 34,356 | 14.97M |
| 456 | QNCX | Quince Therapeutics, Inc. | 24.41M | 6.73% | 54,412 | - |
| 457 | EVAX | Evaxion A/S | 23.27M | -1.06% | 7,808 | 7.53M |
| 458 | LGVN | Longeveron Inc. | 23.13M | 4.35% | 293,461 | 1.22M |
| 459 | CVM | CEL-SCI Corporation | 21.85M | 7.76% | 668,355 | - |
| 460 | CLRB | Cellectar Biosciences, Inc. | 21.26M | 3.50% | 47,900 | - |
| 461 | NEUP | Neuphoria Therapeutics Inc. | 21.24M | 1.29% | 57,873 | -13.27K |
| 462 | SKYE | Skye Bioscience, Inc. | 20.53M | 2.76% | 102,247 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 20.34M | 7.96% | 65,429 | 3.55M |
| 464 | ALLR | Allarity Therapeutics, Inc. | 20.21M | 4.96% | 64,985 | 345.00K |
| 465 | PLRZ | Polyrizon Ltd. | 19.82M | -5.87% | 95,332 | - |
| 466 | GRDX | GridAI Technologies Corp. | 19.36M | 0.34% | 24,987 | - |
| 467 | DARE | Daré Bioscience, Inc. | 19.17M | 4.92% | 126,432 | 1.16M |
| 468 | CELU | Celularity Inc. | 19.11M | 3.92% | 34,466 | 26.55M |
| 469 | TVRD | Tvardi Therapeutics, Inc. | 18.95M | -3.81% | 216,191 | - |
| 470 | ATOS | Atossa Therapeutics, Inc. | 18.69M | 4.83% | 24,066 | - |
| 471 | QNTM | Quantum BioPharma Ltd. | 18.52M | 5.54% | 44,730 | - |
| 472 | NCEL | NewcelX Ltd. | 18.41M | -2.01% | 16,183 | - |
| 473 | HOWL | Werewolf Therapeutics, Inc. | 17.86M | 4.11% | 415,634 | 21.00M |
| 474 | LPCN | Lipocine Inc. | 17.40M | -0.47% | 91,258 | 2.00M |
| 475 | PLUR | Pluri Inc. | 16.99M | 1.61% | 2,998 | 1.08M |
| 476 | JSPR | Jasper Therapeutics, Inc. | 16.97M | -3.76% | 322,108 | - |
| 477 | NRSN | NeuroSense Therapeutics Ltd. | 16.51M | 0.39% | 452,319 | - |
| 478 | CTXR | Citius Pharmaceuticals, Inc. | 16.36M | 4.56% | 318,968 | 5.61M |
| 479 | NXTC | NextCure, Inc. | 15.89M | 6.15% | 446,614 | - |
| 480 | OSRH | OSR Health, Inc. | 15.66M | -0.42% | 333,173 | 2.63M |
| 481 | PTN | Palatin Technologies, Inc. | 15.57M | 6.88% | 12,179 | 12.88M |
| 482 | HIND | Vyome Holdings, Inc. | 15.20M | 2.36% | 11,044 | 152.72K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 14.92M | -2.89% | 341,974 | - |
| 484 | CYCN | Cyclerion Therapeutics, Inc. | 14.80M | 1.45% | 5,179 | 1.99M |
| 485 | KALA | KALA BIO, Inc. | 14.56M | 3.59% | 57,191 | - |
| 486 | MLEC | Moolec Science SA | 14.50M | 3.57% | 7,594 | 7.83M |
| 487 | PASG | Passage Bio, Inc. | 14.40M | 0.45% | 6,954 | - |
| 488 | COCP | Cocrystal Pharma, Inc. | 12.96M | 14.63% | 417,374 | 225.00K |
| 489 | TPST | Tempest Therapeutics, Inc. | 12.96M | 2.20% | 104,208 | - |
| 490 | BLRX | BioLineRx Ltd. | 12.90M | -5.78% | 5,068 | 1.40M |
| 491 | AKTX | Akari Therapeutics, Plc | 12.88M | -6.36% | 24,024 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 12.85M | 2.08% | 46,834 | 1.44M |
| 493 | BIOT | Instinct Bio Technical Company Holdings Inc. | 12.53M | -7.78% | 1,155,642 | - |
| 494 | BIVI | BioVie Inc. | 12.22M | 6.58% | 119,436 | - |
| 495 | PBM | Psyence Biomedical Ltd. | 12.02M | -0.63% | 31,392 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 11.97M | 0.49% | 67,884 | - |
| 497 | CALC | CalciMedica, Inc. | 11.89M | -24.73% | 1,131,852 | - |
| 498 | CMMB | Chemomab Therapeutics Ltd. | 11.66M | 4.52% | 77,294 | - |
| 499 | SNTI | Senti Biosciences Holdings, Inc. | 11.53M | 8.69% | 137,496 | 38.00K |
| 500 | INTS | Intensity Therapeutics, Inc. | 11.51M | 2.65% | 12,016 | - |